EAHAD/LinkedIn
May 21, 2026, 07:23
EAHAD Highlights the Power of Clinical Trials in Haemophilia
EAHAD (European Association for Haemophilia and Allied Disorders) shared a post on LinkedIn:
“This Clinical Trials Day, we recognize the critical role that clinical research plays in driving innovation and improving outcomes for people living with haemophilia.
Within this context, the EAHAD Gene Therapy Trials Database provides a publicly accessible resource that consolidates the latest published gene therapy data, with a particular focus on safety outcomes.
By bringing structured and up-to-date evidence into one place, the platform supports a clearer understanding of ongoing and completed clinical research in the field.
Access the database.”
Stay updated with Hemostasis Today.
-
Aug 22, 2026, 07:45Ziad Hijazi: Refining Risk Assessment in Atrial Fibrillation Without Oral Anticoagulation
-
Aug 22, 2026, 07:35Archil Jaliashvili: The Real Battle Is Not About Blood Volume — It Is About Oxygen
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation